Apyx Medical Stock Forecast for 2023 - 2025 - 2030
Updated on 04/27/2024
Apyx Medical Stock Forecast and Price Target
The average price target for Apyx Medical's stock lately set by several renowned analysts is $2.25, which would result in a potential upside of approximately 55.17% if it reaches this mark by December 31, 2024. This estimation is based on a high estimate of $8.00 and a low estimate of $2.00. You may be interested in rivals even if you aren't interested in Apyx Medical stock.
55.17% Upside
Apyx Medical Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Apyx Medical's Price has grown by 100.00%, from $0.00 to $0.00. For the next year, analysts are expecting Fair Value to reach $1.56 – an increase of 100.00%. Over the next seven years, experts predict that Fair Value will grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BHC Stock Forecast | Bausch Health Companies | Hold |
15
|
$8.71 | Buy/Sell | $9.50 | 9.07% |
| INMD Stock Forecast | InMode | Outperform |
16
|
$17.14 | Buy/Sell | $35.40 | 63.36% |
| UTMD Stock Forecast | Utah Medical Products | - |
18
|
$73.10 | Buy/Sell | $0.00 | -100.00% |
| 1696 Stock Forecast | Sisram Medical Ltd | Buy |
16
|
HK$3.54 | Buy/Sell | HK$1.26 | -77.97% |
| CUTR Stock Forecast | Cutera | Outperform |
6
|
$2.12 | Buy/Sell | $7.67 | 183.02% |
Apyx Medical Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Apyx Medical's Revenue has grown by 60.63%, from $27.71M to $44.51M. For the next year, analysts are expecting Revenue to reach $70.81M – an increase of 59.09%. Over the next seven years, experts predict that Revenue will grow by 633.81%.
.jpg)
Apyx Medical EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Apyx Medical's EBITDA has grown by 18.07%, rising from $-19.20M to $-22.67M. In the following year, 3 experts forecast that Apyx Medical's EBITDA will decrease by 58.98%, to $-9.30M. In 2030, professionals predict that Apyx Medical's EBITDA will decrease by 138.54%, to $8.74M.
Apyx Medical EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Apyx Medical's EBIT has grown, rising from $-20.08M to $-23.56M – a growth of 17.33%. 4 analysts predict Apyx Medical's EBIT will decrease by 39.64% in the next year, reaching $-14.22M. By 2030, professionals predict that Apyx Medical's EBIT will decrease by 377.25%, to $65.32M.
Apyx Medical EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Apyx Medical's EPS has grown by 100.00%, from $-0.35 to $0.00. For the next year, analysts are expecting EPS to reach $-0.46 – an increase of 100.00%. Over the next seven years, experts predict that EPS will grow by 100.00%.
.jpg)